Centre National de la Recherche Scientifique (CNRS);Institut National de la Sante et de la Recherche Medicale (INSERM);Institut National Transfusion Sanguine;Universite Paris Diderot Paris 7
发明人:
Chene, Arnaud,Gamain, Benoît,Gangnard, Stéphane
申请号：
AU2016372447
公开号：
AU2016372447A1
申请日:
2016.12.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention generally relates to an immunogenic construct,useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism,to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
